24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Richard Francis
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:01
AI-powered sports broadcaster Pixellot appoints Doron Gerstel as CEO
19:46
Cellebrite CEO Yossi Carmil retires following record-breaking $100M quarter
19:18
Full list of Israeli high-tech funding rounds in 2024
18:28
Kardome secures $10M Series A for spatial hearing AI technology
More stories
Buzz
Most popular
Daily
Weekly
1
Intel brings back free coffee, considering return of company cars
2
CrowdStrike acquires Adaptive Shield in $300M deal to boost SaaS security
3
Intel aims to net billions in Altera stake sale, targeting $17 billion valuation
4
Wiz eyeing Dazz acquisition in deal worth hundreds of millions
5
From Iron Dome to F-15s: US provides 70% of Israel’s war costs
More news
Richard Francis
2 stories about Richard Francis
Teva soars with double-digit growth in Q3, raises annual forecast
06.11.24
|
Sophie Shulman
Strong sales of Austedo and Ajovy push Teva’s revenues above expectations, with the company forecasting up to $16.5 billion in 2024.
Teva CEO: "The company played not to lose, now we’ll play to win"
21.02.24
|
Sophie Shulman
Richard Francis' decision to focus on innovative drugs has boosted the stock by 40% since he took office. However, the high debt is still burdensome and the realization of the potential depends on the success of developments that are still in the laboratory
Please ensure Javascript is enabled for purposes of
website accessibility